通过ByeTAC:绕过以E-Ligase为目标的奇默体,直接降解蛋白质酶
Cody A Loy1, Eslam M H Ali1, Laurence J Seabrook1
1Department of Pharmaceutical Sciences, University of California, Irvine, California 92617, United States.
Journal of medicinal chemistry
|April 19, 2025
概括
一种新的方法,ByeTAC,直接将向蛋白质组的向蛋白质招募到降解中,绕过了对E3结合酶的需求. 这一进步扩大了针对治疗开发的向蛋白质降解策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 有针对性的蛋白质降解是一种强大的治疗策略.
- 目前的方法依赖于E3结合酶,限制应用到随处可见的准备蛋白.
- 开发新的降解途径对于扩大治疗潜力至关重要.
研究的目的:
- 引入一种针对蛋白质降解的新方法.
- 为了克服E3酶依赖性降解的局限性.
- 为了证明蛋白质直接招募到蛋白质酶体进行降解.
主要方法:
- 设计的双功能分子 (ByeTACs) 将一个小分子连接体与26S蛋白酶子单元连接起来.
- 利用Rpn-13,26S蛋白质组的非必不可少的泛素受体,用于招募.
- 证明了目标蛋白质的降解,独立于E3结合酶级联.
主要成果:
- 成功生成了针对蛋白质降解的ByeTACs.
- 通过与Rpn-13和感兴趣的蛋白质结合,ByeTACs调解降解.
- 降解发生在不需要内源性无化途径的情况下.
结论:
- 拜泰克 (ByeTAC) 方法提供了一种针对蛋白质降解的新方法.
- 通过Rpn-13直接招募到蛋白质酶体,绕过了E3结合酶的依赖性.
- 这一策略扩大了治疗应用的蛋白酶介导降解的范围.
相关概念视频
The Proteasome
779
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
779
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
The Proteasome Structure
645
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
645
Export of Misfolded Proteins out of the ER
3.3K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.3K


